Tyrosine Kinase Inhibitor Therapy Induces Remission in a Patient With Refractory <i>EBF1-PDGFRB</i>–Positive Acute Lymphoblastic Leukemia

2013212 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 31, Issue 25, pp. e413-e416

Field-Weighted Citation Impact: 15.14